These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 4324570)

  • 1. [Clinical and hormonal evaluation of the corticotropic effect of delayed-action beta 1-24 tetracosapeptide].
    Strumia E; Bellucci Sessa M; Molinatti GM
    Minerva Med; 1970 Jan; 61(1):10-8. PubMed ID: 4324570
    [No Abstract]   [Full Text] [Related]  

  • 2. [Adrenocorticotropic effects of beta 1-24 tetracosapeptide. (Study of excretion of 17-OHCS, of 17-KS and of pregnanetriol)].
    Vizzone A; Caprioli N; Rasconà F
    Quad Clin Ostet Ginecol; 1966 Dec; 21(12):1191-7. PubMed ID: 4296898
    [No Abstract]   [Full Text] [Related]  

  • 3. [Functional evaluation of the adrenal cortex in acromegalic patients: test of fast stimulation with synthetic ACTH (beta 1-24 corticotropin)].
    Boni M
    Endocrinol Sci Cost; 1968 Jun; 29(6):442-6. PubMed ID: 4311125
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacodynamic evaluation of synthetic prolonged-action ACTH on the adrenal function of patients with hypothalamo-pituitary pathology. Comparative study of synthetic ACTH and extra-delayed-action gel].
    Artese R; De Laszlo MH; Molocznik I; Varela J; Guitelman A; Brussino M; Dickmann GH; Montes ME
    Prensa Med Argent; 1971 Jan; 57(46):2088-97. PubMed ID: 4326359
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative studies of the effect of ACTH prolongatum Polfa and corticotropin Organon on the function of the adrenal cortex].
    Mazanek E; Buntner B
    Pol Tyg Lek; 1971 Aug; 26(31):1203-5. PubMed ID: 4328805
    [No Abstract]   [Full Text] [Related]  

  • 6. Corticoadrenal stimulation with different doses of a repository tetracosapeptide.
    Poggi UL; Argüelles AE; Checkerdemian M; Martĩnez MA; Pucciarelli E
    Rev Argent Endocrinol Metab; 1970 Mar; 16(1):31-40. PubMed ID: 4331168
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of effects of corticotrophin and corticosteroids on pituitary-adrenal function.
    Carter ME; James VH
    Ann Rheum Dis; 1971 Jan; 30(1):91-7. PubMed ID: 4323367
    [No Abstract]   [Full Text] [Related]  

  • 8. Adrenocorticotrophic potency of long-acting corticotrophin preparations during long-term treatment of neurological patients.
    Rinne UK
    Ann Med Intern Fenn; 1968; 57(4):167-72. PubMed ID: 4307479
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of different types of ACTH in the evaluation of patients with hypophyseal tumors. Findings in 28 cases].
    Artese R; Molocznik I; Guitelman A; Dickmann GH; Varela J; Schalit LG; Martinez Montes M
    Prensa Med Argent; 1968 Sep; 55(30):1453-62. PubMed ID: 4303518
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of delayed-action Cortrosyn (Tetracosactide) in rheumatology. Apropos of 32 cases].
    Lièvre JA; Guillien P
    Brux Med; 1970 Dec; 50(12):1103-12. PubMed ID: 4322894
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapy of bronchial asthma with synthetic delayed-action corticotropin].
    Andersson E; Lorenzen J
    Nord Med; 1968 Aug; 80(32):1050-2. PubMed ID: 4301738
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current status of treatment with a synthetic corticotropic peptide, tetracosactide-retard].
    Deguillaume R
    Presse Med (1893); 1971 Jan; 79(6):233-5. PubMed ID: 4323028
    [No Abstract]   [Full Text] [Related]  

  • 13. [Adrenal circadian rhythm and delayed-action corticoids].
    D'Agata R; Mughini L; Distefano C; Ferlito S
    Rass Neurol Veg; 1969; 23(5):219-29. PubMed ID: 4328313
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of intra-articular and intraspinal corticotherapy on the hypophyso-adrenal axis].
    Oliver C; Lapousse JC; Maestracci D; d' Omezon Y; Vague P; Hawthorn E
    Rhumatologie; 1971 Nov; 23(9):323-30. PubMed ID: 4333924
    [No Abstract]   [Full Text] [Related]  

  • 15. [Persistance of the adrenocortical circadian rhythm in the course of submaximal corticoid inhibition obtained with a preparation with delayed absorption].
    Ceresa F; Angeli A; Boccuzzi G; Perotti L; Molino G
    Folia Endocrinol; 1968 Feb; 21(1):1-17. PubMed ID: 4301491
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies of the potency of polypeptides with ACTH action by a new method based on continuous measurement of plasma corticosterone.
    Hajós GT; Szporny L; Kárpáti E; Fekete G
    Steroids Lipids Res; 1972; 3(4):225-8. PubMed ID: 4348818
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of synthetic ACTH on adrenocortical function in man and in the rat.
    László FA; Kovács K; Faredin I; Czakó L; Durszt F; Szijj I; Tóth I; Biró A; Julesz M
    Acta Med Acad Sci Hung; 1970; 27(3):223-33. PubMed ID: 4324707
    [No Abstract]   [Full Text] [Related]  

  • 18. [Indications, possibilities and limits of corticostimulation in current practice].
    Codaccioni JL; Boyer J
    Rev Prat; 1972 Nov; 22(30):Suppl:84-6. PubMed ID: 4347614
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutical possibilities of a synthetic delayed action tetracosapeptide (ACTH-like) in dermatology].
    Sartoris S; Pippione M; Strani GF
    G Ital Dermatol Minerva Dermatol; 1969 Jun; 44(6):301-10. PubMed ID: 5409070
    [No Abstract]   [Full Text] [Related]  

  • 20. [Corticosteroidogenesis inhibitors. II. A new cortico-adrenal inhibitor: amino-glutethimide (16,038Ba)].
    Philbert M; Luton JP; Mathieu de Fossey B; Bricaire H
    Presse Med (1893); 1968 May; 76(23):1107-10. PubMed ID: 5657304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.